Fluorescence Lifetime Spectroscopy in Cardioand Neuroimaging

Advances in Optical Imaging for Clinical Medicine

Volumn , Issue , 2011, Pages 255-285

  Marcu, Laura ^a   Jo, Javier A ^b   Butte, Pramod ^c  

^a University of California Davis   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Fluorescence lifetime spectroscopy in cardio and neuroimaging; Fluorescence, ubiquitous approach achieving optical molecular contrast using range of instruments; Time resolved laser induced fluorescence spectroscopy (TR LIFS) distinguishing tumor tissue from normal brain matter

Indexed keywords

EID: 84858798895     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470767061.ch9     Document Type: Chapter

References (101)

1. Lakowicz, J.R., Principles of Fluorescence Spectroscopy, 2nd ed., Kluwer Academic/Plenum Press, New York, 1999.
2. Richards-Kortum, R., and Sevick-Muraca, E.M., Quantitative optical spectroscopy for tissue diagnosis, Annu. Rev. Phys. Chem., Vol. 47, 1996, pp. 555-606.
3. Wagnieres, G.A., Star, W.M., and Wilson, B.C., In vivo fluorescence spectroscopy and imaging for oncological applications, Photochem. Photobiol., Vol. 68, No. 5, 1998, pp. 603-632.
4. Mycek, M.-A., and Pogue, B.W. (eds.), Handbook of Biomedical Fluorescence, Marcel Dekker, New York, 2003.
5. Andersson-Engels, S., et al., In vivo fluorescence imaging for tissue diagnostics, Phys. Med. Biol., Vol. 42, 1997, pp. 815-824.
6. Bigio, I.J., and Mourant, J.R., Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy, Phys. Med. Biol., Vol. 42, 1997, pp. 803-814.
7. Cubeddu, R., et al., Time-resolved fluorescence imaging in biology and medicine, J. Phys. D, Vol. 35, 2002, pp. R61-R76.
8. Das, B.B., Liu, F., and Alfano, R.R., Time-resolved fluorescence and photon migration studies in biomedical and model random media, Rep. Prog. Phys., Vol. 60, 1997, pp. 227-292.
9. Drezek, R.A., et al., Optical imaging of the cervix, Cancer, Vol. 98, 2003, pp. 2015-2027.
10. Glanzmann, T., et al., Time-resolved spectrofluorometer for clinical tissue characterization during endoscopy, Rev. Sci. Instrum., Vol. 70, 1999, pp. 4067-4077.
11. Mycek, M.A., Schomacker, K.T., and Nishioka, N.S., Colonic polyp differentiation using time-resolved autofluorescence spectroscopy, Gastrointest. Endosc., Vol. 48, 1998, pp. 390-394.
12. Ramanujam, N., Fluorescence spectroscopy of neoplastic and non-neoplastic tissues, Neoplasia, Vol. 2, 2000, pp. 89-117.
13. Utzinger, U., and Richards-Kortum, R.R., Fiber optic probes for biomedical optical spectroscopy, J. Biomed. Opt., Vol. 8, 2003, pp. 121-147.
14. Papazoglou, T.G., et al., Laser-induced fluorescence detection of cardiovascular atherosclerotic deposits via their natural emission and hypocrellin (Ha) probing, J. Photochem. Photobiol. B, Vol. 22, 1994, pp. 139-144.
15. Morguet, A.J., et al., Autofluorescence spectroscopy using a XeCl excimer laser system for simultaneous plaque ablation and fluorescence excitation, Lasers Surg. Med., Vol. 14, 1994, pp. 238-248.
16. Morguet, A.J., et al., Development and evaluation of a spectroscopy system for classification of laser-induced arterial fluorescence spectra, Biomed. Technol. (Berl.), Vol. 42, 1997, pp. 176-182.
17. Baraga, J.J., et al., Laser induced fluorescence spectroscopy of normal and atherosclerotic human aorta using 306-310nm excitation, Lasers Surg. Med., Vol. 10, 1990, pp. 245-261.
18. Bartorelli, A.L., et al., In vivo human atherosclerotic plaque recognition by laser-excited fluorescence spectroscopy, J. Am. Coll. Cardiol., Vol. 17, 1991, pp. 160B-168B.
19. Christov, A., et al., "Optical detection of triggered atherosclerotic plaque disruption by fluorescence emission analysis," Photochem. Photobiol., Vol. 72, 2000, pp. 242-252.
20. Arakawa, K., et al., "Fluorescence analysis of biochemical constituents identifies atherosclerotic plaque with a thin fibrous cap," Arterioscler., Thromb. Vasc. Biol., Vol. 22, 2002, pp. 1002-1007.
21. Marcu, L., Grundfest, W.S., and Fishbein, M., Time-resolved laser-induced fluorescence spectroscopy for staging atherosclerotic lesions, in Fluorescence in Biomedicine, M.-A. Mycek and B. Pogue (eds.), Marcel Dekker, New York, 2002.
22. Elson, D.S., et al., "Multidimensional Fluorescence Imaging applied to biological tissues," in Annual Reviews in Fluorescence 2006, C.D. Geddes and J.R. Lakowicz (eds.), Springer, 2006.
23. http://www.picoquant.com/.
24. http://www.becker-hickl.de/.
25. Fang, Q.Y., et al., Time-domain laser-induced fluorescence spectroscopy apparatus for clinical diagnostics, Rev. Sci. Instrum., Vol. 75, 2004, pp. 151-162.
26. Pitts, J.D., and Mycek, M.-A., Design and development of a rapid acquisition laserbased fluorometer with simultaneous spectral and temporal resolution, Rev. Sci. Instrum., Vol. 72, 2001, p. 3061.
27. Pfefer, T.J., et al., Temporally and spectrally resolved fluorescence spectroscopy for the detection of high grade dysplasia in Barrett's esophagus, Lasers Surg. Med., Vol. 32, No. 1, 2003, pp. 10-16.
28. Marcu, L., et al., Applications of time-resolved fluorescence spectroscopy to atherosclerotic cardiovascular disease and brain tumors diagnosis, CLEO/QELS, Baltimore, May 22-27, 2005, Vol. 1, pp. CFJ3-J5.
29. Marcu, L., et al., In-vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy, Atherosclerosis, Vol. 181, No. 2, 2005, pp. 295-303.
30. Marcu, L., et al., Detection of rupture-prone atherosclerotic plaques by time-resolved laser induced fluorescence spectroscopy, Atherosclerosis, Vol. 204, No. 1, 2008, pp. 156-164.
31. Yong, W.H., et al., Distinction of brain tissue, low grade and high grade glioma with time-resolved fluorescence spectroscopy, Front. Biosci., Vol. 11, 2006, pp. 1255-1263.
32. Butte, P.V., et al., Diagnosis of meningiomas by time-resolved fluorescence spectroscopy, J. Biomed. Opt., Vol. 10, No. 6, 2005, p. 064026.
33. Marcu, L., et al., Fluorescence lifetime spectroscopy of glioblastoma multiforme, Photochem. Photobiol., Vol. 80, No. 1, 2004, pp. 95-103.
34. Ashjian, P., et al., Non-invasive in-situ evaluation of osteogenic differentiation by time-resolved laser-induced fluorescence spectroscopy, Tissue Eng., Vol. 10, No. 3-4, 2004, pp. 411-420.
35. Marcu, L., et al., Discrimination of lipid-rich atherosclerotic lesions of human coronary artery by time-resolved laser-induced fluorescence spectroscopy, Arterioscler. Thromb. Vasc. Biol., Vol. 21, 2001, pp. 1244-1250.
36. Maarek, J.M., et al., Time-resolved fluorescence of aortic wall: use for improved identification of atherosclerotic lesions, Lasers Surg. Med., Vol. 27, 2000, pp. 241-254.
37. Sun, Y.H., et al., Simultaneous time-and wavelength-resolved fluorescence spectroscopy for near real-time tissue diagnosis, Opt. Lett., Vol. 33, No. 6, 2008, pp. 630-632.
38. Ware, W.R., Doemeny, L.J., and Nemzek, T.L., Deconvolution of fluorescence and phosphorescence decay curves: least-squares method, J. Phys. Chem., Vol. 77, No. 17, 1973, pp. 2038-2048.
39. O'Connor, D.V., Ware, W.R., and Andre, J.C., Deconvolution of fluorescence decay curves: critical comparison of techniques, J. Phys. Chem., Vol. 83, No. 10, 1979, pp. 1333-1343.
40. Maarek, J.M.I., et al., Time-resolved fluorescence spectra of arterial fluorescent compounds: reconstruction with the Laguerre expansion technique, Photochem. Photobiol., Vol. 71, No. 2, 2000, pp. 178-187.
41. Jo, J.A., et al., Fast model-free deconvolution of fluorescence decay for analysis of biological systems, J. Biomed. Opt., Vol. 9, No. 4, 2004, pp. 743-752.
42. Marmarelis, V.Z., Identification of nonlinear biological-systems using Laguerre expansions of kernels, Ann. Biomed. Eng., Vol. 21, No. 6, 1993, pp. 573-589.
43. Stavridi, M., Marmarelis, V.Z., and Grundfest, W.S., Spectro-temporal studies of Xe-Cl excimer laser-induced arterial-wall fluorescence, Med. Eng. Phys., Vol. 17, No. 8, 1995, pp. 595-601.
44. Snyder, W.J., et al., Biologic fluorescence decay characteristics: determination by Laguerre expansion technique, Proc. SPIE, Vol. 2679, 1996, p. 150.
45. Jo, J.A., et al., Laguerre-based method for analysis of time-resolved fluorescence data: application to in-vivo characterization and diagnosis of atherosclerotic lesions, J. Biomed. Opt., Vol. 11, No. 2, 2006, p. 021004.
46. Naghavi, M., et al., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: I, Circulation, Vol. 108, 2003, pp. 1664-1672.
47. Libby, P., and Aikawa, M., Stabilization of atherosclerotic plaques: new mechanisms and clinical targets, Nat. Med., Vol. 8, 2002, pp. 1257-1262.
48. MacNeill, B.D., et al., Intravascular modalities for detection of vulnerable plaque: current status, Arterioscler. Thromb. Vasc. Biol., Vol. 23, 2003, pp. 1333-1342.
49. Tearney, G.J., et al., Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography, Circulation, Vol. 107, 2003, pp. 113-119.
50. Jang, I.K., Tearney, G., and Bouma, B., Visualization of tissue prolapse between coronary stent struts by optical coherence tomography: comparison with intravascular ultrasound, Circulation, Vol. 104, 2001, p. 2754.
51. Hatsukami, T.S., et al., Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging, Circulation, Vol. 102, 2000, pp. 959-964.
52. Zimmermann, G.G., et al., Intravascular MR imaging of atherosclerotic plaque: ex vivo analysis of human femoral arteries with histologic correlation, Radiology, Vol. 204, 1997, pp. 769-774.
53. de Korte, C.L., et al., Morphological and mechanical information of coronary arteries obtained with intravascular elastography: feasibility study in vivo, Eur. Heart J., Vol. 23, 2002, pp. 405-413.
54. Foster, F.S., et al., Advances in ultrasound biomicroscopy, Ultrasound Med. Biol., Vol. 26, 2000, pp. 1-27.
55. Jang, I.K., et al., Comparison of optical coherence tomography and intravascular ultrasound for detection of coronary plaques with large lipid-core in living patients, Circulation, Vol. 102, 2000, p. 509.
56. Maruvada, S., Shung, K.K., and Wang, S.H., High-frequency backscatter and attenuation measurements of porcine erythrocyte suspensions between 30-90MHz, Ultrasound Med. Biol., Vol. 28, 2002, pp. 1081-1088.
57. Saijo, Y., and Steen, A.F.W., Vascular Ultrasound, Springer, Tokyo, 2003.
58. Yock, P.G., and Fitzgerald, P.J., Intravascular ultrasound: state of the art and future directions, Am. J. Cardiol., Vol. 81, 1998, pp. 27E-32E.
59. Bouma, B.E., et al., Evaluation of intracoronary stenting by intravascular optical coherence tomography, Heart, Vol. 89, 2003, pp. 317-320.
60. Fujimoto, J.G., et al., High resolution in vivo intra-arterial imaging with optical coherence tomography, Heart, Vol. 82, 1999, pp. 128-133.
61. Verheye, S., et al., In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition, Circulation, Vol. 105, 2002, pp. 1596-1601.
62. Casscells, W., et al., Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis, Lancet, Vol. 347, 1996, pp. 1447-1451.
63. Stefanadis, C., et al., Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques, Eur. Heart J., Vol. 23, 2002, pp. 1664-1669.
64. Moreno, P.R., and Muller, J.E., Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods, Curr. Opin. Cardiol., Vol. 17, 2002, pp. 638-647.
65. Fayad, Z.A., and Fuster, V., Clinical imaging of the high-risk or vulnerable atherosclerotic plaque, Circ. Res., Vol. 89, 2001, pp. 305-316.
66. Pasterkamp, G., et al., Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making, J. Am. Coll. Cardiol., Vol. 36, 2000, pp. 13-21.
67. Honda, Y., and Fitzgerald, P.J., Frontiers in intravascular imaging technologies, Circulation, Vol. 117, 2008, pp. 2024-2037.
68. Papazoglou, T.G., et al., Laser-induced fluorescence detection of cardiovascular atherosclerotic deposits via their natural emission and hypocrellin (Ha) probing, J. Photochem. Photobiol. B, Vol. 22, 1994, pp. 139-144.
69. Morguet, A.J., et al., Autofluorescence spectroscopy using a XeCl excimer laser system for simultaneous plaque ablation and fluorescence excitation, Lasers Surg. Med., Vol. 14, 1994, pp. 238-248.
70. Baraga, J.J., et al., Laser induced fluorescence spectroscopy of normal and atherosclerotic human aorta using 306-310nm excitation, Lasers Surg. Med., Vol. 10, 1990, pp. 245-261.
71. Bartorelli, A.L., et al., In vivo human atherosclerotic plaque recognition by laser-excited fluorescence spectroscopy, J. Am. Coll. Cardiol., Vol. 17, 1991, pp. 160B-168B.
72. Christov, A., et al., Optical detection of triggered atherosclerotic plaque disruption by fluorescence emission analysis, Photochem. Photobiol., Vol. 72, 2000, pp. 242-252.
73. Arakawa, K., et al., Fluorescence analysis of biochemical constituents identifies atherosclerotic plaque with a thin fibrous cap, Arterioscler. Thromb. Vasc. Biol., Vol. 22, 2002, pp. 1002-1007.
74. Angheloiu, G.O., et al., Intrinsic fluorescence and diffuse reflectance spectroscopy identify superficial foam cells in coronary plaques prone to erosion, Arterioscler. Thromb. Vasc. Biol., Vol. 26, 2006, pp. 1594-1600.
75. Gropler, R.J., and Soto, P., Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient, Curr. Cardiol. Rep., Vol. 6, 2004, pp. 20-26.
76. Tsimikas, S., Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies, Am. J. Cardiol., Vol. 90, 2002, pp. 22L-27L.
77. Virmani, R., et al., Pathology of the vulnerable plaque, J. Am. Coll. Cardiol., Vol. 47, 2006, pp. 13-18.
78. CBTRUS, 2002-2004 Statistical Report: Primary Brain Tumors in the United States, 1995-1999, Central Brain Tumor Registry of the United States, Hinsdale, IL, 2008.
79. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavanee, W.K., WHO Classification of Tumors of Central Nervous System, Lyon, France, International Agency for Research on Cancer, 2007.
80. Mirimanoff, R.O., et al., Meningioma: analysis of recurrence and progression following neurosurgical resection, J. Neurosurg., Vol. 62, No. 1, 1985, pp. 18-24.
81. Bruner, J.M., Neuropathology of malignant gliomas, Semin. Oncol., Vol. 21, No. 2, 1994, pp. 126-138.
82. Stummer, W., et al., Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias, Neurosurgery, Vol. 62, No. 3, 2008, pp. 564-576.
83. Krammer, B., et al., ALA and its clinical impact, from bench to bedside, Photochem. Photobiol. Sci., Vol. 7, No. 3, 2008, pp. 283-289.
84. Unsgaard, G., et al., Brain operations guided by real-time two-dimensional ultrasound: new possibilities as a result of improved image quality, Neurosurgery, Vol. 51, No. 2, 2002, pp. 402-412.
85. Sutherland, G.R., and Louw, D.F., Intraoperative MRI: a moving magnet, Can. Med. Assoc. J., Vol. 161, 1999, p. 1293.
86. Kollias, S.S., et al., Target definition and trajectory optimization for interactive MRguided biopsies of brain tumors in an open configuration MRI system, J. Magn. Reson. Imaging, Vol. 8, 1998, pp. 143-159.
87. Stummer, W., et al., Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report, J. Neurooncol., Vol. 87, No. 1, 2008, pp. 103-109.
88. Chung, Y.G., et al., Diagnostic potential of laser-induced autofluorescence emission in brain tissue, J. Korean Med. Sci., Vol. 12, No. 2, 1997, pp. 135-142.
89. Croce, A.C., et al., Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins, Photochem. Photobiol., Vol. 77, No. 3, 2003, pp. 309-318.
90. Lin, W.C., et al., In vivo brain tumor demarcation using optical spectroscopy, Photochem. Photobiol., Vol. 73, No. 4, 2001, pp. 396-402.
91. Lin, W.C., et al., Brain tumor demarcation using optical spectroscopy: an in vitro study, J. Biomed. Opt., Vol. 5, No. 2, 2000, pp. 214-220.
92. Marcu, L., et al., Fluorescence lifetime spectroscopy of glioblastoma multiforme, Photochem. Photobiol., Vol. 80, 2004, pp. 98-103.
93. Yong, W.H., et al., Distinction of brain tissue, low grade and high grade glioma with time-resolved fluorescence spectroscopy, Front. Biosci., Vol. 11, 2006, pp. 1255-1263.
94. Butte, P.V., et al., Diagnosis of meningioma by time-resolved fluorescence spectroscopy, J. Biomed. Opt., Vol. 10, No. 6, 2005, p. 064026.
95. Bottiroli, G., et al., Natural fluorescence of normal and neoplastic human colon: a comprehensive "ex vivo" study, Lasers Surg. Med., Vol. 16, No. 1, 1995, pp. 48-60.
96. Lin, W.C., et al., In vivo optical spectroscopy detects radiation damage in brain tissue, Neurosurgery, Vol. 57, No. 3, 2005, pp. 518-525.
97. Toms, S.A., et al., Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity, Neurosurgery, Vol. 57, No. 4, Suppl., 2005, pp. 382-391.
98. Pradhan, A., et al., Steady state and time-resolved fluorescence properties of metastatic and non-metastatic malignant cells from different species, J. Photochem. Photobiol. B, Vol. 31, No. 3, 1995, pp. 101-112.
99. Reinert, K.C., et al., Flavoprotein autofluorescence imaging of neuronal activation in the cerebellar cortex in vivo, J. Neurophysiol., Vol. 92, No. 1, 2004, 199-211.
100. Bottiroli, G., et al., Brain tissue autofluorescence: an aid for intraoperative delineation of tumor resection margins, Cancer Detect. Prev., Vol. 22, No. 4, 1998, pp. 330-339.
101. Jo, J.A., et al., A nonlinear model of cardiac autonomic control in obstructive sleep apnea syndrome, Ann. Biomed. Eng., Vol. 35, No. 8, 2007, pp. 1425-1443.